GSK, Novartis pledge funds for diseases that mostly affect the poor

1 min


163
102 shares, 163 points

By Natalie Grover and Jennifer Rigby

LONDON (Reuters) – GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders and health experts gather in Rwanda to discuss ways to better combat illnesses affecting more than a billion people, mostly in impoverished communities.

The intention is to spur a renewed effort to address some 20 diseases that have been eradicated in the developed world – ranging from leprosy to rabies – after the work in these areas was knocked off track by the economic toll of the pandemic.

GSK pledged to spend 1 billion pounds ($1.23 billion) over the next decade on developing medicines and vaccines to tackle neglected tropical diseases (NTDs), as well as infectious diseases such as malaria, tuberculosis and HIV, which disproportionately affect lower-income countries.

The London-based company, which pioneered the first malaria vaccine, has carved out and will invest in a specific global health unit that will not generate a profit for GSK. It has more than 30 drugs and vaccines in its pipeline for the effort, including products designed to deal with antimicrobial resistance.

Swiss drugmaker Novartis has vowed to spend $250 million over the next five years to develop interventions to tackle NTDs and malaria.

Of that, $100 million has been earmarked for Chagas disease, leishmaniasis, dengue and cryptosporidiosis. The remainder has been set aside to address malaria, which killed more than half a million people in 2020, most of them children under the age of five in the poorest parts of Africa.

“Large medicine donations without sustainable supply nor innovation investments are ill-suited to the challenge of NTD control,” said Dr. Bernard Pecoul, executive director of Drugs for Neglected Diseases  initiative (DNDi), a non-profit research and development organization.

“With climate change set to increase the burden of NTDs … and to hit the most vulnerable hardest,” he said, “now is the time to make a real commitment to research and development for NTDs.”

($1 = 0.8153 pound)

(Reporting by Natalie Grover and Jennifer Rigby in London; Editing by Bill Berkrot)

Source: KFGO


Like it? Share with your friends!

163
102 shares, 163 points

What's Your Reaction?

Cute Cute
26
Cute
Fun Fun
18
Fun
Hate Hate
13
Hate
Confused Confused
2
Confused
Fail Fail
21
Fail
Geeky Geeky
16
Geeky
Love Love
8
Love
OMG OMG
2
OMG
Choose A Format
Personality quiz
Series of questions that intends to reveal something about the personality
Trivia quiz
Series of questions with right and wrong answers that intends to check knowledge
Poll
Voting to make decisions or determine opinions
Story
Formatted Text with Embeds and Visuals
List
The Classic Internet Listicles
Countdown
The Classic Internet Countdowns
Open List
Submit your own item and vote up for the best submission
Ranked List
Upvote or downvote to decide the best list item
Meme
Upload your own images to make custom memes
Video
Youtube, Vimeo or Vine Embeds
Audio
Soundcloud or Mixcloud Embeds
Image
Photo or GIF
Gif
GIF format